FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Register
horizonal rule

 

Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Cellular, Tissue and Gene Therapies Advisory Committee

March 29-30, 2007

Glenn Dranoff, M.D.

  • 18 U.S.C. 208 waiver (pdf)

Mary M. Horowitz, M.D.

  • 18 U.S.C. 208 waiver (pdf)

Maha Hussian, M.D., FACP

  • 18 U.S.C. 208 waiver (pdf)

Mary J. Laughlin, M.D.

  • 18 U.S.C. 208 waiver (pdf)

James J. Mule, Ph.D.

  • 18 U.S.C. 208 waiver (pdf)

Derek Raghavan, M.D., Ph.D. (Dr. Raghavan was unable to attend this meeting)

  • 18 U.S.C. 208 waiver (pdf)

Howard I. Scher, M.D.

  • 18 U.S.C. 208 waiver (pdf)

Savio L. C. Woo, Ph.D.

  • 18 U.S.C. 208 waiver (pdf)

Page updated: March 28, 2007

horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Registers
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management
[Skip Navigation] link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page